Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma
Clinical trial NCT05161143 · UNKNOWN
Trial details
- NCT number
- NCT05161143
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.